Oxford Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,202
| Closed | -$1.55M | – | 753 |
|
|
2025
Q1 | $1.55M | Buy |
+3,202
| New | +$1.55M | 0.74% | 20 |
|
|
2024
Q4 | – | Sell |
-689
| Closed | -$320K | – | 596 |
|
|
2024
Q3 | $320K | Buy |
+689
| New | +$320K | 0.27% | 149 |
|
|
2024
Q1 | – | Sell |
-508
| Closed | -$207K | – | 363 |
|
|
2023
Q4 | $207K | Buy |
+508
| New | +$207K | 0.31% | 138 |
|
|
2020
Q1 | – | Sell |
-7,846
| Closed | -$1.72M | – | 1287 |
|
|
2019
Q4 | $1.72M | Buy |
+7,846
| New | +$1.72M | 0.05% | 512 |
|
|
2019
Q3 | – | Sell |
-6,740
| Closed | -$1.24M | – | 1965 |
|
|
2019
Q2 | $1.24M | Sell |
6,740
-4,106
| -38% | -$753K | 0.03% | 873 |
|
|
2019
Q1 | $2M | Sell |
10,846
-23,825
| -69% | -$4.38M | 0.04% | 581 |
|
|
2018
Q4 | $5.75M | Buy |
+34,671
| New | +$5.75M | 0.15% | 158 |
|
|
2018
Q3 | – | Sell |
-14,682
| Closed | -$2.45M | – | 1942 |
|
|
2018
Q2 | $2.45M | Sell |
14,682
-5,706
| -28% | -$952K | 0.05% | 538 |
|
|
2018
Q1 | $3.32M | Buy |
+20,388
| New | +$3.32M | 0.07% | 317 |
|
|
2017
Q3 | – | Sell |
-34,803
| Closed | -$4.49M | – | 1722 |
|
|
2017
Q2 | $4.49M | Buy |
34,803
+2,042
| +6% | +$263K | 0.09% | 234 |
|
|
2017
Q1 | $3.58M | Buy |
+32,761
| New | +$3.58M | 0.09% | 224 |
|
|
2015
Q3 | – | Sell |
-2,187
| Closed | -$270K | – | 729 |
|
|
2015
Q2 | $270K | Buy |
+2,187
| New | +$270K | 0.01% | 577 |
|